Concepedia

Michael Snaith

MS

Statistics

Publications

16

Citations

1K

H-Index

16

Active since

1995

Affiliations

AstraZeneca (Sweden)(Current)

University of Cambridge

AstraZeneca (United Kingdom)

University of Gothenburg

Recombinant Antibody Technology (United Kingdom)

Michael Snaith is an author at AstraZeneca (Sweden) specializing in life sciences, molecular biology, and metabolic regulation.

Publications per year

1995–2021

16

Publications

16

Ablation of PGC-1β Results in Defective Mitochondrial Activity, Thermogenesis, Hepatic Function, and Cardiac Performance

Christopher J. Lelliott, Gema Medina‐Gómez, Nataša Petrovič et al. · PLoS Biology · 2006 · 271 citations · Full text

, , +17

Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation

E. Suzanne Cohen, Ian C. Scott, Jayesh B. Majithiya et al. · Nature Communications · 2015 · 267 citations · Full text

, , +17

FLP recombinase in transgenic plants: constitutive activity in stably transformed tobacco and generation of marked cell clones in <i>Arabidopsis</i>

Nigel J. Kilby, Gareth Davies, Michael Snaith et al. · The Plant Journal · 1995 · 100 citations · Full text

, , +13

Phenotypic screening of hepatocyte nuclear factor (HNF) 4-γ receptor knockout mice

Anna Karin Gerdin, Vikas V. Surve, Marie E. Jönsson et al. · Biochemical and Biophysical Research Communications · 2006 · 53 citations

, , +9

Osteoporosis in MCHR1-deficient mice

Mohammad Bohlooly‐Y, Margit Mahlapuu, Harriet Andersén et al. · Biochemical and Biophysical Research Communications · 2004 · 43 citations

, , +9

1–5 of 16